NLRP3 and acute respiratory distress syndrome: II/R stimulates the release of lipid mediators, which can enhance the expression of NLRP3 inflammatory bodies and the production of IL-1β in pulmonary vascular endothelial cells, thereby increasing pulmonary vascular permeability and the inflammatory response and resulting in ALI.